INTERNATIONALLY-RECOGNIZED ACADEMIC SCIENTISTS JOIN ROCHE BIOSCIENCE ADVISORY BOARD
Palo Alto, Calif., April 8, 1998 -- Eight scientists, including Harvard Nobel laureate E.J. Corey, Ph.D., are members of a newly-formed Roche Bioscience Scientific Advisory Board. Known for their basic research and clinical expertise in areas including neurobiology and immunology, the advisors will review early Roche Bioscience programs and will provide critical evaluations of research assumptions from an academic perspective. The group met in Palo Alto for the first meeting last month.
"Our new advisory board will interact with scientists at all levels of our company who are working on truly novel new therapies for arthritis, asthma, inflammation, pain and urinary tract and other disorders," said Roche Bioscience President James N. Woody, M.D., Ph.D. "We will discuss issues and opportunities with our advisors. We expect them to challenge our assumptions, help us solve problems and bring new ideas to our research efforts."
In addition to Corey, who won the 1990 Nobel Prize in chemistry and is a continuing advisor to Roche, the board includes:
Leslie Z. Benet, Ph.D, professor and chair of biopharmaceutical sciences University of California at San Francisco School of Pharmacy;
Dennis Choi, M.D., Ph.D., chairman of neurology at Washington University, St. Louis;
Ron W. Davis, Ph.D, director of Stanford DNA Sequencing and Technology Center and professor of biochemistry and genetics at the Stanford University Medical Center;
Marc Feldmann, M.D., Ph.D, Kennedy Institute of Rheumatology, Sunley Division, England;
Larry Steinmann, M.D., professor of neurology at the Stanford University Medical Center;
Greg L. Verdine, Ph.D., professor of chemical biology at Harvard University, and
Charles Weissmann, M.D., Ph.D, member, Roche Holding Ltd board of directors and professor, Institute of Molecular Biology, Universitat H?nggerberg, Switzerland.
Located in Palo Alto, Calif., Roche Bioscience is a research-based, business-oriented enterprise dedicated to the discovery and early clinical development of innovative prescription drugs. Roche Bioscience is part of the Roche Group headquartered in Basel, Switzerland.
###
